Overexpression of cell-surface GRP78 has been identified in various cancer types, including prostate [5], gastric [6], ovarian [7], thyroid [8], skin [9], and breast cancer making GRP78 a promising target for cancer-treatment. This evidence concerns the gene HSPA5 and breast carcinoma.